Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis
Clinical trial NCT05863936 · UNKNOWN
Trial details
- NCT number
- NCT05863936
- Sponsor
- Nanjing University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.